Pregabalin and Muscle disorder - a phase IV clinical study of FDA data

Summary:

Muscle disorder is reported as a side effect among people who take Pregabalin (pregabalin), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Ocrevus, and have Relapsing-remitting multiple sclerosis.

The phase IV clinical study analyzes which people have Muscle disorder when taking Pregabalin. It is created by eHealthMe based on reports of 73,056 people who have side effects when taking Pregabalin from the FDA, and is updated regularly.

What is Pregabalin?

Pregabalin has active ingredients of pregabalin. It is often used in fibromyalgia. eHealthMe is studying from 74,069 Pregabalin users. Check the latest studies of Pregabalin.

What is Muscle disorder?

Muscle disorder (muscle disease) is found to be associated with 733 drugs and 841 conditions by eHealthMe. Check the latest studies of Muscle disorder.

On Jul, 07, 2026

73,056 people reported to have side effects when taking Pregabalin.
Among them, 25 people (0.03%) have Muscle disorder.

Among these 25 people:

How long have people been on Pregabalin when they have Muscle disorder? *

What is the gender of people who have Muscle disorder when taking Pregabalin? *

female: 47.83 %
male: 52.17 %

What is the age of people who have Muscle disorder when taking Pregabalin? *

What are other drugs people take besides Pregabalin? *

What are other side effects people have besides Muscle disorder? *

Joint Pain: 17 people, 68.00%
Fatigue (feeling of tiredness): 12 people, 48.00%
Rashes (redness): 10 people, 40.00%
Gait Disturbance: 8 people, 32.00%
Muscle Aches (muscle pain): 6 people, 24.00%
Weakness: 6 people, 24.00%
Back Pain: 6 people, 24.00%
Bone Pain: 6 people, 24.00%
Temperature Intolerance (inability to go in temperature): 5 people, 20.00%
Memory Loss: 5 people, 20.00%

What are the existing conditions these people have? *

High Blood Pressure: 5 people, 20.00%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 5 people, 20.00%
Stress And Anxiety: 3 people, 12.00%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 12.00%
Prostate Cancer: 3 people, 12.00%
High Blood Cholesterol: 2 people, 8.00%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 8.00%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 8.00%
Blood Uric Acid Increased: 1 person, 4.00%
Depression: 1 person, 4.00%

* Approximation only. Some reports may have incomplete information.

Do you take Pregabalin and have Muscle disorder?

- Check whether Muscle disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pregabalin:

Pregabalin (74,069 reports)

Muscle disorder treatments and more:

Muscle disorder (11,686 reports)

Browse all side effects of Pregabalin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Muscle disorder:

Muscle disorder (733 drugs)

Browse all the conditions that are associated with Muscle disorder:

Muscle disorder (841 conditions)

Related publications that referenced our studies

de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
Bonnet U, Taazimi B, Grabbe HD, "Pregabalin-Related Hypertriglyceridemia", Psychosomatics, 2014 Nov .
de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
Bonnet U, Taazimi B, Grabbe HD, "Pregabalin-Related Hypertriglyceridemia", Psychosomatics, 2014 Nov .

How the study uses the data?

The study uses data from the FDA. It is based on pregabalin (the active ingredients of Pregabalin) and Pregabalin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.